PipeA. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance. Clin J Sport Med. 2004;14:188-189.
2.
BoozerCNDalyPAHomelP. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. Int J Obes Relat Metab Disord. 2002;26:593-604.
3.
CoffeyCSSteinerDBakerBAAllisonDB. A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment. Int J Obes Relat Metab Disord. 2004;28:1411-1419.
4.
PoddarKKolgeSBezmanLMullinGECheskinLJ. Nutraceutical supplements for weight loss: a systematic review. Nutr Clin Pract. 2011;26:539-552.
5.
ShekellePGHardyMLMortonSC. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA. 2003;289:1537-1545.
6.
DiepvensKKovacsEMVogelsNWesterterp-PlantengaMS. Metabolic effects of green tea and of phases of weight loss. Physiol Behav. 2006;87:185-191.
7.
HurselRWesterterp-PlantengaMS. Thermogenic ingredients and body weight regulation. Int J Obes. 2010;34:659-669.
8.
PhungOJBakerWLMatthewsLJLanosaMThorneAColemanCI. Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis. Am J Clin Nutr. 2010;91:73-81.
9.
JurgensTMWhelanAMKillianLDoucetteSKirkSFoyE. Green tea for weight loss and weight maintenance in overweight or obese adults. Cochrane Database Syst Rev. 2012;12:CD008650.
10.
BaladiaEBasultoJManeraMMartinezRCalbetD. Effect of green tea or green tea extract consumption on body weight and body composition: systematic review and meta-analysis [in Spanish]. Nutr Hosp. 2014;29:479-490.
11.
HannanJMAliLRokeyaB. Soluble dietary fibre fraction of Trigonella foenum-graecum (fenugreek) seed improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion and absorption, and enhancing insulin action. Br J Nutr. 2007;97:514-521.
12.
XueWLLiXSZhangJLiuYHWangZLZhangRJ. Effect of Trigonella foenum-graecum (fenugreek) extract on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats. Asia Pac J Clin Nutr. 2007;16(suppl 1):422-426.
13.
AnnidaBStanely Mainzen PrinceP. Supplementation of fenugreek leaves reduces oxidative stress in streptozotocin-induced diabetic rats. J Med Food. 2005;8:382-385.
14.
DakamWShangJAgborGObenJ. Effects of sodium bicarbonate and albumin on the in vitro water-holding capacity and some physiological properties ofTrigonella foenum graecum L. galactomannan in rats. J Med Food. 2007;10:169-174.
15.
KassaianNAzadbakhtLForghaniBAminiM. Effect of fenugreek seeds on blood glucose and lipid profiles in type 2 diabetic patients. Int J Vitam Nutr Res. 2009;79:34-39.
16.
GuptaAGuptaRLalB. Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study. J Assoc Physicians India. 2001;49:1057-1061.
17.
MarlettJAMcBurneyMISlavinJL; American Dietetic Association. Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc. 2002;102:993-1000.
18.
KarhunenLJJuvonenKRFlanderSM. A psyllium fiber-enriched meal strongly attenuates postprandial gastrointestinal peptide release in healthy young adults. J Nutr. 2010;140:737-744.
19.
DelargyHJO’SullivanKRFletcherRJBlundellJE. Effects of amount and type of dietary fibre (soluble and insoluble) on short-term control of appetite. Int J Food Sci Nutr. 1997;48:67-77.
20.
SartoreGReitanoRBarisonA. The effects of psyllium on lipoproteins in type II diabetic patients. Eur J Clin Nutr. 2009;63:1269-1271.
21.
ZiaiSALarijaniBAkhoondzadehS. Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients. J Ethnopharmacol. 2005;102:202-207.
22.
CiceroAFDerosaGMancaMBoveMBorghiCGaddiAV. Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial. Clin Exp Hypertens. 2007;29:383-394.
23.
CiceroAFTartagniEErtekS. Nutraceuticals for metabolic syndrome management: from laboratory to benchside. Curr Vasc Pharmacol. 2014;12(4):565-571.
24.
PalSRadavelli-BagatiniS. Effects of psyllium on metabolic syndrome risk factors. Obes Rev. 2012;13:1034-1047.
25.
PalSKhossousiABinnsCDhaliwalSEllisV. The effect of a fibre supplement compared to a healthy diet on body composition, lipids, glucose, insulin and other metabolic syndrome risk factors in overweight and obese individuals. Br J Nutr. 2011;105:90-100.
26.
MoranSMilkePRodriguez-LealGUribeM. Ref: Gallstone formation in obese subjects undergoing a weight reduction diet. Int J Obes Relat Metab Disord. 1998;22:282-284.
27.
KhossousiABinnsCWDhaliwalSSPalS. The acute effects of psyllium on postprandial lipaemia and thermogenesis in overweight and obese men. Br J Nutr. 2008;99:1068-1075.
28.
Rodriguez-MoranMGuerrero-RomeroFLazcano-BurciagaG. Lipid- and glucose-lowering efficacy of Plantago psyllium in type II diabetes. J Diabetes Complications. 1998;12:273-278.
29.
TaiESFokACChuRTanCE. A study to assess the effect of dietary supplementation with soluble fibre (Minolest) on lipid levels in normal subjects with hypercholesterolaemia. Ann Acad Med Singapore. 1999;28:209-213.
30.
VuksanVJenkinsALRogovikALFairgrieveCDJovanovskiELeiterLA. Viscosity rather than quantity of dietary fibre predicts cholesterol-lowering effect in healthy individuals. Br J Nutr. 2011;106:1349-1352.
31.
SaperRBEisenbergDMPhillipsRS. Common dietary supplements for weight loss. Am Fam Physician. 2004;70:1731-1738.
32.
Hasani-RanjbarSJouyandehZAbdollahiM. A systematic review of anti-obesity medicinal plants—an update. J Diabetes Metab Disord. 2013;12:28.
33.
KeithleyJSwansonB. Glucomannan and obesity: a critical review. Alt Ther Health Med. 2005;11:30-34.
34.
KeithleyJKSwansonBMikolaitisSL. Safety and efficacy of glucomannan for weight loss in overweight and moderately obese adults. J Obes. 2013;2013:610908.
35.
PittlerMHErnstE. Dietary supplements for body-weight reduction: a systematic review. Am J Clin Nutr. 2004;79:529-536.
36.
CiceroAFErtekSBorghiC. Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management. Curr Vasc Pharmacol. 2009;7:330-337.
MicallefMMunroIPhangMGargM. Plasma n-3 polyunsaturated fatty acids are negatively associated with obesity. Br J Nutr. 2009;102:1370-1374.
39.
HeymsfieldSBAllisonDBVasselliJRPietrobelliAGreenfieldDNunezC. Garcinia cambogia(hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. JAMA. 1998;280:1596-1600.
40.
VasquesCARossettoSHalmenschlagerG. Evaluation of the pharmacotherapeutic efficacy of Garcinia cambogia plus Amorphophallus konjac for the treatment of obesity. Phytother Res. 2008;22:1135-1140.
41.
KovacsEMWesterterp-PlantengaMSde VriesMBrounsFSarisWH. Effects of 2-week ingestion of (–)-hydroxycitrate and (–)-hydroxycitrate combined with medium-chain triglycerides on satiety and food intake. Physiol Behav. 2001;74:543-549.
42.
PreussHGGarisRIBrambleJD. Efficacy of a novel calcium/potassium salt of (–)-hydroxycitric acid in weight control. Int J Clin Pharmacol Res. 2005;25:133-144.
43.
PreussHGBagchiDBagchiMRaoCVDeyDKSatyanarayanaS. Effects of a natural extract of (–)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss. Diabetes Obes Metab. 2004;6:171-180.
44.
LimSYoonJWChoiSH. Effect of ginsam, a vinegar extract from Panax ginseng, on body weight and glucose homeostasis in an obese insulin-resistant rat model. Metabolism. 2009;58:8-15.
45.
MollahMLKimGSMoonHK. Antiobesity effects of wild ginseng (Panax ginseng C.A. Meyer) mediated by PPAR-gamma, GLUT4 and LPL in ob/ob mice. Phytother Res. 2009;23:220-225.
46.
SotaniemiEAHaapakoskiERautioA. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care. 1995;18:1373-1375.
47.
KovacsEMWesterterp-PlantengaMSSarisWHGoossensIGeurtenPBrounsF. The effect of addition of modified guar gum to a low-energy semisolid meal on appetite and body weight loss. Int J Obes Relat Metab Disord. 2001;25:307-315.
48.
EvansEMillerDS. Bulking agents in the treatment of obesity. Nutr Metab. 1975;18:199-203.
49.
KovacsEMWesterterp-PlantengaMSSarisWH. The effect of guar gum addition to a semisolid meal on appetite related to blood glucose, in dieting men. Eur J Clin Nutr. 2002;56:771-778.
50.
PittlerMHErnstE. Guar gum for body weight reduction: meta-analysis of randomized trials. Am J Med. 2001;110:724-730.
